跳至主要内容
临床试验/CTRI/2025/10/095599
CTRI/2025/10/095599尚未招募3 期

Clinical study of Madhu- Ghrita mishrita Tilkalka lepa in post operated cases of Nadi Vrana W.S.R. to Pilonidal Sinus

Dr. Alok Kumar1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2025年11月10日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
45
试验地点
1
主要终点
Improvement in pain and tenderness of Pilonidal Sinus (Nadi Vrana)

研究概览

简要总结

Shalyajanya Nadi vrana can be correlated with pilonidal sinus in the modern concept . pilonidal sinus is an epithelium lined tract .situated short distance behind the anus . in the sacrococcygeal area natal cleft containing hairs and unhealthy granulated tissue .It is due to penetration of hairs through the skin into subcutaneous tissue Itcauses recurrencet infection abscess formatin which bursts open forming recurrent sinus with pain discharge and discomfort .The several methods to treat pilonidal sinus such as wide excision bascom cleft lift technique various types of flaps However post operative recurrence following surgery is high leading to frequent and time consuming wound care .

Local application of Madhu Ghrita mishrita Tilkalka lepa helps in shodhan and ropan of the vrana .So in this research work an attemptis made to evaluate the efficacy of Madhu Ghrita mishrita Tilkalka lepa  application is better for healing in post operated cases of Nadi Vrana .

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients willing to undergo trial and give informed written consent.
  • Patients of either sex above 20 years and below 60 years of age.
  • Excised cases of Pilonidal Sinus (Nadi Vrana).
  • Excised cases of Pilonidal sinus with a maximum length of 5 cm.

排除标准

  • Patients of age below 20 years and above 60 years.
  • Patients having multiple sinus track .
  • Pilonidal sinus more than 5 cm in length.
  • Patients suffering from Systemic disease like Diabetese Mellitus.
  • , Hypertension ,T.B. ,Malignancy .
  • HIV,HCV,HBsAg positive subjects.

结局指标

主要结局

Improvement in pain and tenderness of Pilonidal Sinus (Nadi Vrana)

时间窗: 1 Month | The trial drug will be given for 1 month and follow up will be done after 2 months

次要结局

  • Relief in pain tenderness and Discharge of Nadi Vrana (Pilonidal Sinus)(After analyzing all the parameters the result will be assessed on the basis of symptomatic relief and improvement)

研究者

发起方
Dr. Alok Kumar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Alok Kumar

Vaidya Yagya Dutt Sharma Ayurveda Mahavidyalya Khurja Bulandshahar Uttar Pradesh

研究点 (1)

Loading locations...

相似试验